Device-detected atrial fibrillation: Anticoagulation may have greater benefit in patients with vascular disease
A combined subgroup analysis of the similar trials NOAH—AFNET 6 and ARTESiA has revealed that patients with device-detected atrial fibrillation and concomitant vascular disease are at higher risk of stroke and cardiovascular ...
Sep 2, 2024
0
0